Soligenix (SNGX) Asset Utilization Ratio (2011 - 2024)
Soligenix's (SNGX) quarterly Asset Utilization Ratio came in at 0.01 in Q4 2024, down 84.57% YoY from 0.08 in Q1 2024, and down 65.71% on a QoQ basis from 0.04 in Q3 2024.
Soligenix (SNGX) Asset Utilization Ratio (2011 - 2024) Analysis & Trends
Soligenix (SNGX) has 14 years of Asset Utilization Ratio data on file, last reported at 0.01 in Q4 2024.
- Quarterly Asset Utilization Ratio fell 84.57% year-over-year to 0.01 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was 0.01 (down 84.57% YoY) and the FY2024 annual result came in at 0.01, down 81.75% from the prior year.
- Asset Utilization Ratio fell to 0.01 in Q4 2024, from 0.04 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.56 in Q1 2020 to a low of 0.01 in Q4 2024.
- A 5-year average of 0.12 and a median of 0.07 in 2022 frame the typical range for Asset Utilization Ratio.
- Annual changes were most pronounced in 2021 — Asset Utilization Ratio slumped 86.49% — and 2023, when it jumped 134.44%.
- Tracing SNGX's Asset Utilization Ratio over 5 years: stood at 0.17 in 2020, then sank by 82.47% to 0.03 in 2021, then surged by 102.14% to 0.06 in 2022, then surged by 35.1% to 0.08 in 2023, then tumbled by 84.57% to 0.01 in 2024.
- The last three Asset Utilization Ratio figures came in at 0.01 (Q4 2024), 0.04 (Q3 2024), and 0.06 (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 0.20 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.69 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 0.90 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.13 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 0.54 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.13 |
| 10 | Soligenix | 6.45 Mn | 6.45 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 0.01 |
| Sep 30, 2024 | 0.04 |
| Jun 30, 2024 | 0.06 |
| Mar 31, 2024 | 0.08 |
| Dec 31, 2023 | 0.08 |
| Sep 30, 2023 | 0.08 |
| Jun 30, 2023 | 0.08 |
| Mar 31, 2023 | 0.08 |
| Dec 31, 2022 | 0.06 |
| Sep 30, 2022 | 0.04 |
| Jun 30, 2022 | 0.04 |
| Mar 31, 2022 | 0.03 |
| Dec 31, 2021 | 0.03 |
| Sep 30, 2021 | 0.04 |
| Jun 30, 2021 | 0.06 |
| Mar 31, 2021 | 0.08 |
| Dec 31, 2020 | 0.17 |
| Sep 30, 2020 | 0.32 |
| Jun 30, 2020 | 0.39 |
| Mar 31, 2020 | 0.56 |